Cargando…
Genomewide Association Studies in Pharmacogenomics
The increasing availability of genotype data linked with information about drug‐response phenotypes has enabled genomewide association studies (GWAS) that uncover genetic determinants of drug response. GWAS have discovered associations between genetic variants and both drug efficacy and adverse drug...
Autores principales: | McInnes, Gregory, Yee, Sook Wah, Pershad, Yash, Altman, Russ B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8376796/ https://www.ncbi.nlm.nih.gov/pubmed/34185318 http://dx.doi.org/10.1002/cpt.2349 |
Ejemplares similares
-
Genomewide Pharmacogenomic Analysis of Response to Treatment with Antipsychotics
por: McClay, Joseph L., et al.
Publicado: (2009) -
Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs
por: Adkins, Daniel E., et al.
Publicado: (2010) -
Pathway and network embedding methods for prioritizing psychiatric drugs
por: Pershad, Yash, et al.
Publicado: (2020) -
Genomewide Association Study of Platelet Reactivity and Cardiovascular Response in Patients Treated With Clopidogrel: A Study by the International Clopidogrel Pharmacogenomics Consortium
por: Verma, Shefali Setia, et al.
Publicado: (2020) -
Drug Response Pharmacogenetics for 200,000 UK Biobank Participants
por: McInnes, Gregory, et al.
Publicado: (2021)